Navigation Links
MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
Date:2/5/2008

Presentation will be webcast live and archived on Company's web site

GERMANTOWN, Md., Feb. 5 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that Dr. Edward M. Rudnic, MiddleBrook president and CEO, will deliver a corporate presentation on Monday, February 11, 2008, at 11:45 a.m. Eastern Time.

The presentation will take place as part of the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2008 at the Waldorf Astoria hotel in New York, New York. Dr. Rudnic's remarks will be available live on the MiddleBrook web site, where they also will be archived for 30 days.

To access the presentation, log on to http://www.middlebrookpharma.com and click on the Presentations option in the Investor Relations section. Please connect to the web site several minutes prior to the start of the live presentation to ensure adequate time for any software download that may be necessary.

About MiddleBrook Pharmaceuticals:

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is a pharmaceutical company focused on the development and commercialization of anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease. The Company is developing anti-infective drugs based on its novel biological finding that bacteria exposed to antibiotics in front-
'/>"/>

SOURCE MiddleBrook Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
2. Celator(R) Pharmaceuticals to Present at 10th Annual BIO CEO and Investor Conference
3. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
4. Anthera Pharmaceuticals Forms Scientific Advisory Board
5. Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
6. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
10. Sagent Pharmaceuticals, Inc. to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Access Pharmaceuticals Announces $2.7 Million New Equity

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...one hybrid . . . , Fuel economy ratings for th...t the www.fueleconomy.gov web site, which Oak Ri...r the U.S. Department of Energy and the U.S. Envir...icles on the best fuel economy list are hybrid ele...ighway). "This list proves that hybrids have gone ...
(Date:11/5/2009)...Nov. 5 DSM Pharmaceutical Products...alliance with Galenix, Saint Jean D,Illac, France,...manufacturing partner for Galenix commercial produ...collaborate on business development opportunities ...ased on the strength of Galenix in drug product de...
(Date:11/5/2009)... Thursday, November 5, 2009 at 4:30 p.m. Eastern T...swire-FirstCall/ - OncoGenex Pharmaceuticals, Inc....oday reported unaudited financial results for the ...2009 and reviewed the Company,s highlights for the...idated results reflect the operations of OncoGenex...
(Date:11/5/2009)... Nov. 5 Cepheid (Nasdaq:...be speaking at the following investor conferences,... , , Credit Suisse Healthcare Conf...November, 2009 at 10 a.m. Mountain Time, ...England, Tuesday, 1 December, 2009...
Breaking Biology Technology:November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8Cepheid to Webcast Upcoming Financial Presentations 2
...cals, Inc. (Nasdaq: ALSE ) today announced that ... public accounting firm regarding the Company,s 20...aragraph regarding the Company,s ability to contin...quire NASDAQ-traded companies to publicly announce...udit report containing a going concern explanatory...
...,s leading independent research institutes is expa...align to support the critical mission of protectin... needed bioenergy solutions. , , Officials at ...hat they are expanding MRI,s existing operations b...stitute that will be named Midwest Research Instit...
...l event for health care leaders in businesses, gov... D.C. , , WASHINGTON, March 31 The 6th Annual...on, D.C., is pleased to announce several foreign d...to meet with top health leaders from the United St...e delegations will represent the spectrum of forei...
Other Biology Technology:Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K 2Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K 3Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 2Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 3Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 4Health Care Innovations and Opportunities Attract Attendees from 40 Countries and Delegations from 12 to 6th Annual World Health Care Congress 2
(Date:11/4/2009)...y bacteria, it turns out, hold the power to help m...d the world clean up toxic waste on test sites. ,... were invented back in World War II and have been ...h-energy compounds are often used to propel tank s... , But with increased knowledge of their envir...
(Date:11/4/2009)...Calif., Oct. 19 Spectros, develope...nd imaging devices which shed light on life-threat... exclusive distribution deals for both its T-Stat&...s covered include Australia, New Zealand, The Net... Italy, France, Spain, Portugal, Poland, Greece, T...
(Date:11/4/2009)...Oct. 20 Aware, Inc. (Nas...nology and biometrics software, today reported fin...ber 30, 2009. ,, Michael Tzannes, Aware,s Cha...today, we announced an agreement to sell our DSL a...fabless semiconductor company being spun out of In...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2Spectros Signs New International Distribution Deals 2Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7KTA Capital Advises SpringTree Global Investors on an AU 247 2 Million Investment in HealthLinx Ltd 58917 1KTA Capital Advises SpringTree Global Investors on an AU 247 2 Million Investment in HealthLinx Ltd 58917 2The American Academy of Family Physicians Launches Consumer Alliance With First Partner 3A The Coca Cola Company 58914 1The American Academy of Family Physicians Launches Consumer Alliance With First Partner 3A The Coca Cola Company 58914 2The American Academy of Family Physicians Launches Consumer Alliance With First Partner 3A The Coca Cola Company 58914 3The American Academy of Family Physicians Launches Consumer Alliance With First Partner 3A The Coca Cola Company 58914 4Galenea Awarded RC1 Challenge Grant to Develop Predictive In Vivo Models of Cognition 58911 1Galenea Awarded RC1 Challenge Grant to Develop Predictive In Vivo Models of Cognition 58911 2
...s ago, a "new" amino acid was added to the alphabe...s today. Now researchers at Yale and the Universit...cid and, by example, other amino acids made its ... appeared in the December 31 advance online public...cid the Yale researchers studied, pyrrolysine (Pyl...
...French . , Montreal, January 27, 2008 The futur...cifically a part metal and part flesh human being ...e main character in the Six Million Dollar Man was... a multidisciplinary team of scientists led by the...produce new metal surfaces that promise to lead to...
... to predict the impact of climate change on the de...stralia information that could help limit its spr...new issue of the British Ecological Society,s jour...tionary change could act together to accelerate an... in the form of storing water to cope with climat...
Other Biology News:'Fishy' clue helps establish how proteins evolve 2New generation of orthopedic, dental and cardiovascular prostheses 2Hoarding rainwater could 'dramatically' expand range of dengue-fever mosquito 2
MiniPrep from Tecan
...used as an internal standard for the quantificatio...trometry. 5-OxoETE is a polyunsaturated keto acid ...hils. It stimulates cytosolic calcium levels in ne...ly stimulates the migration and degranulation of e...
...eam System Delivers 4,600 to Over 3 Million Genoty...tem is capable of performing 4,600 to over 3 Milli... of products*, this automated, scalable, multiplex...f an arrayed 384-well plate, for cost-effective hi...
...ize markers are a mixture of Strep•Tag® I...markers provide precise size references for protei...Coomassie blue. Because each of the proteins conta...n also be detected by the Strep•Tag II Monocl...
Biology Products: